Dear Colleagues

Thank you for joining the APAC 2022 Kick Off: Something Evolving meeting!

The APAC 2022 Kick Off opened a critical year for the BioMarin team, with upcoming launches in achondroplasia and hemophilia, entry into new markets, and ongoing efforts to secure market leadership with our existing portfolio.

We will meet these opportunities with an updated launch excellence 2.0 program, a fit-for-growth mindset and readiness to engage with customers in new ways. With one team, one voice, we will innovate and accelerate to our goal of bringing new therapies to patients with rare diseases.

Thank you for joining us to explore these strategies as a team as we evolve in 2022!